Information was received from a healthcare professional (hcp) manufacturer representative (rep) regarding a patient who was receiving morphine, 20 mg/ml concentration at 2.246 mg/day dose via intrathecal drug delivery pump for non-malignant pain.It was reported that patient called the healthcare professional (hcp)'s office to inform office staff that her pump had started alarming on monday, (b)(6)`.She had also noticed her pain had started increasing.Patient may have reached its elective replacement indicator (eri).At patient's last refill in (b)(6) 2017, estimated eri was 6 months.Patient was due for a pump refill in (b)(6), but the hcp's office had called her before her refill appointment to inform her that the hcp was dropped and it was effective (b)(6) 2018.She would need to either find a new provider or change her insurance that covered appointments at the office.Patient was provided the names of the insurances that cover visits with the hcp.Drug in pump was over 6 months old.Diagnostics/troubleshooting that was performed was unknown.Patient was instructed to call the hospital to get the names of providers she could see for her pump refills and pump replacement.At the time of this report, the issue was not resolved and patient status was alive-no injury.Surgical intervention did not occur and it was unknown if it was planned.No further complications were reported.
|